Felipe Mendes Zorzi
Biographic Data
| ID | 10242379 |
|---|---|
| NAME | Felipe Mendes Zorzi |
| GIVEN NAMES | Felipe Mendes |
| FAMILY NAME | Zorzi |
| SIGNATURE | ZORZI F M |
| AFFILIATIONS | Universidade de São Paulo |
| ORCID | 0000-0002-3042-1856 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2020 |
| H-INDEX | 0 |
Coexistence of the Oxazolidinone Resistance–Associated Genes cfr and optrA in Enterococcus faecalis From a Healthy Piglet in Brazil
Oxazolidinones are one of the most important antimicrobials potentially active against glycopeptide-and -lactam-resistant Gram-positive pathogens. Linezolid-the first oxazolidinone to be approved for clinical use in 2000 by the US Food and Drug Administration-and the newer molecule in the class, tedizolid, inhibit protein synthesis by suppressing the formation of the 70S ribosomal complex in bacteria. Over the past two decades, transferable oxazo…
No prominent works on this page.
Coexistence of the Oxazolidinone Resistance–Associated Genes cfr and optrA in Enterococcus faecalis From a Healthy Piglet in Brazil
Oxazolidinones are one of the most important antimicrobials potentially active against glycopeptide-and -lactam-resistant Gram-positive pathogens. Linezolid-the first oxazolidinone to be approved for clinical use in 2000 by the US Food and Drug Administration-and the newer molecule in the class, tedizolid, inhibit protein synthesis by suppressing the formation of the 70S ribosomal complex in bacteria. Over the past two decades, transferable oxazo…
Antibiotics (1 work) · Antimicrobial Resistance in Staphylococcus (1 work) · Biology (1 work) · Ecology (1 work) · Enterococcus (1 work) · Enterococcus faecalis (1 work) · Escherichia coli (1 work) · Gene (1 work) · Genetics (1 work) · Medicine (1 work)